SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?


To: Joe Krupa who wrote (6964)3/19/2001 7:52:32 AM
From: Tom Drolet  Read Replies (3) | Respond to of 14101
 
Joe and Wolf:

No, I am not suggesting anything but what I said.

Remember in school, when we were taught Lateral Thinking 301--it was just that--Lateral Thinking--the art of problem solving by looking at the same evidence/facts from another direction to see what different conclusions can be brought out.

That is exactly what everyone has been doing here for years.

I just said to myself--OK--lets try another angle by looking at what has been said recently by DMX (not the Rapp Star) and see if a different end point could bring out a ratioale for why DMX was saying these things they are now!

And--No--I don't know anything factual. No, I don't have an inhouse or outhouse source.

But, ask it another way!

Am I worried that the CHB sent this issue (Pennsaid approval) back for further work some time ago?--Yes, very!

Am I worried that that the FDA is still siting on its mouth after "x" years? Yes--very!

Am I perplexed about confusion re inspections --yes. no, maybe soon??--Yes, very?

Just trying to close all sides of this particular info starved loop of life.

Bottom Line--DMX has decided to go the independant route that it has. That puts it up there high in the Risk vs Reward balancing act category.

Some Goliath mighty Pharma's are aligned against our David DMX.

Anything is possible. --it happens.

Tom D.